Bioventus Stock Today


USD 6.98  0.01  0.14%   

Market Performance
0 of 100
Odds Of Distress
Over 72
Bioventus Inc is selling at 6.98 as of the 24th of September 2022; that is 0.14 percent up since the beginning of the trading day. The stock's lowest day price was 6.75. Bioventus Inc has a very high chance of experiencing financial distress in the next few years of operation. It has also generated negative returns for investors over the last 90 days. Equity ratings for Bioventus Inc Cl are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 25th of August 2022 and ending today, the 24th of September 2022. Click here to learn more.
Bioventus Inc. a medical device company, focuses on developing and commercializing clinical treatments that engage and enhance the bodys natural healing process in the United States and internationally. The companys product portfolio includes pain treatments, which comprise non-surgical joint pain injection therapies, as well as peripheral nerve stimulation products. The company has 59.44 M outstanding shares of which 1.71 M shares are currently shorted by investors with about 5.51 days to cover. More on Bioventus Inc Cl

Moving together with Bioventus Inc

+0.67GEGeneral Electric TrendingPairCorr
Follow Valuation Odds of Bankruptcy
Check how we calculate scores

Bioventus Inc Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Bioventus Inc's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Bioventus Inc or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
Bioventus Inc generated a negative expected return over the last 90 days
Bioventus Inc has high historical volatility and very poor performance
Bioventus Inc has high likelihood to experience some financial distress in the next 2 years
The company reported the last year's revenue of 466.41 M. Reported Net Loss for the year was (52.6 M) with profit before taxes, overhead, and interest of 302.71 M.
About 65.0% of the company shares are held by institutions such as insurance companies
Average Analyst Recommendation
Analysts covering Bioventus Inc report their recommendations after researching Bioventus Inc's financial statements, talking to executives and customers, or listening in on Bioventus Inc's conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering Bioventus Inc. The Bioventus consensus assessment is calculated by taking the average forecast from all of the analysts covering Bioventus Inc.
Strong Buy3 Opinions
Macroaxis Advice
Unlike general analyst consensus, Macroaxis buy hold or sell recommendation is provided in the context of your current investment horizon and risk tolerance. The advice algorithm takes into account all of Bioventus Inc's available fundamental, technical, and predictive indicators. Your current horizon is 90 days - details
Strong SellUndervalued
Bioventus Inc Cl (BVS) is traded on NASDAQ Exchange in USA and employs 1,150 people. The company currently falls under 'Small-Cap' category with total capitalization of 414.88 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Bioventus Inc's market, we take the total number of its shares issued and multiply it by Bioventus Inc's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities. Bioventus Inc runs under Healthcare sector within Medical Devices industry. The entity has 59.44 M outstanding shares of which 1.71 M shares are currently shorted by investors with about 5.51 days to cover. Bioventus Inc Cl has about 27.37 M in cash with 20.01 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.45.
Check Bioventus Inc Probability Of Bankruptcy
Bioventus Inc retains a total of 59.44 Million outstanding shares. Over half of Bioventus Inc outstanding shares are owned by other corporate entities. These other corporate entities are typically referred to corporate investors that acquire positions in a given instrument to benefit from reduced trade commissions. Consequently, these institutions are subject to different rules and regulation than regular investors in Bioventus Inc. Please watch out for any change in the institutional holdings of Bioventus Inc as this could mean something significant has changed or about to change at the company. Remember, it does not matter who owns the company or if the company is currently losing money. If the true value of the company is more than the market pays for it currently, you can still have a good investment opportunity.

Ownership Allocation (%)

Check Bioventus Ownership Details

Bioventus Stock Price Odds Analysis

In regard to a normal probability distribution, the odds of Bioventus Inc jumping above the current price in 90 days from now is under 95%. The Bioventus Inc Cl probability density function shows the probability of Bioventus Inc stock to fall within a particular range of prices over 90 days. Considering the 90-day investment horizon the stock has a beta coefficient of 1.2835 suggesting as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Bioventus Inc will likely underperform. Additionally, the company has a negative alpha, implying that the risk taken by holding this instrument is not justified. Bioventus Inc is significantly underperforming DOW.
  Odds Below 6.98HorizonTargetOdds Above 6.98
5.70%90 days
Based on a normal probability distribution, the odds of Bioventus Inc to move above the current price in 90 days from now is under 95 (This Bioventus Inc Cl probability density function shows the probability of Bioventus Stock to fall within a particular range of prices over 90 days) .

Bioventus Stock Institutional Holders

Institutional Holdings refers to the ownership stake in Bioventus Inc that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Bioventus Inc's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Bioventus Inc's value.
InstituionSecurity TypeTotal SharesValue
Essex Woodlands Management IncCommon Shares12.1 M82.5 M
Juniper Investment Company LlcCommon Shares2.8 M18.8 M
View Bioventus Inc Diagnostics

Bioventus Inc Risk Profiles

Investors will always prefer to have the highest possible return on investment while minimizing volatility. Bioventus Inc market risk premium is the additional return an investor will receive from holding Bioventus Inc long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Bioventus Inc. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although Bioventus Inc's alpha and beta are two of the key measurements used to evaluate Bioventus Inc's performance over the market, the standard measures of volatility play an important role as well.

Bioventus Stock Against Markets

Picking the right benchmark for Bioventus Inc stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Bioventus Inc stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Bioventus Inc is critical whether you are bullish or bearish towards Bioventus Inc Cl at a given time.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Bioventus Inc without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Technical Analysis Now


Technical Analysis

Check basic technical indicators and analysis based on most latest market data
All  Next Launch Module

Invested in Bioventus Inc Cl?

The danger of trading Bioventus Inc Cl is mainly related to its market volatility and company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Bioventus Inc is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Bioventus Inc. The Shape ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Bioventus Inc is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Continue to Trending Equities. You can also try Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.

Complementary Tools for analysis

When running Bioventus Inc price analysis, check to measure Bioventus Inc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bioventus Inc is operating at the current time. Most of Bioventus Inc's value examination focuses on studying past and present price action to predict the probability of Bioventus Inc's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Bioventus Inc's price. Additionally, you may evaluate how the addition of Bioventus Inc to your portfolios can decrease your overall portfolio volatility.
Price Transformation
Use Price Transformation models to analyze depth of different equity instruments across global markets
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Is Bioventus Inc's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bioventus Inc. If investors know Bioventus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bioventus Inc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Bioventus Inc is measured differently than its book value, which is the value of Bioventus that is recorded on the company's balance sheet. Investors also form their own opinion of Bioventus Inc's value that differs from its market value or its book value, called intrinsic value, which is Bioventus Inc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bioventus Inc's market value can be influenced by many factors that don't directly affect Bioventus Inc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bioventus Inc's value and its price as these two are different measures arrived at by different means. Investors typically determine Bioventus Inc value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bioventus Inc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.